These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38821216)

  • 1. Decreasing of serine/threonine kinase 39 has tumour inhibiting effects on acute myeloid leukaemia by impacting the PI3K/AKT and Wnt/β-catenin signalling cascades.
    Li C; Xin H; Hao J; Miao Y
    Toxicol Appl Pharmacol; 2024 Aug; 489():116982. PubMed ID: 38821216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR.
    Chen L; Wan Y; Liu Y; Li T
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin and AKT are promising targets for combination therapy in acute myeloid leukemia.
    Wang L; You LS; Ni WM; Ma QL; Tong Y; Mao LP; Qian JJ; Jin J
    Leuk Res; 2013 Oct; 37(10):1329-40. PubMed ID: 23867056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells.
    Perry JM; Tao F; Roy A; Lin T; He XC; Chen S; Lu X; Nemechek J; Ruan L; Yu X; Dukes D; Moran A; Pace J; Schroeder K; Zhao M; Venkatraman A; Qian P; Li Z; Hembree M; Paulson A; He Z; Xu D; Tran TH; Deshmukh P; Nguyen CT; Kasi RM; Ryan R; Broward M; Ding S; Guest E; August K; Gamis AS; Godwin A; Sittampalam GS; Weir SJ; Li L
    Nat Cell Biol; 2020 Jun; 22(6):689-700. PubMed ID: 32313104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 7. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
    Zhou J; Toh SH; Chan ZL; Quah JY; Chooi JY; Tan TZ; Chong PSY; Zeng Q; Chng WJ
    J Hematol Oncol; 2018 Mar; 11(1):36. PubMed ID: 29514683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUC-7738 regulates β-catenin signalling resulting in reduced proliferation and self-renewal of AML cells.
    Shahid AM; Um IH; Elshani M; Zhang Y; Harrison DJ
    PLoS One; 2022; 17(12):e0278209. PubMed ID: 36520954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACT3 has a tumor-inhibiting role in acute myeloid leukemia via the suppression of Wnt/β-catenin signaling by DVL2.
    Gao Q; Hou L; Wang H; Xun L
    J Biochem Mol Toxicol; 2022 May; 36(5):e23014. PubMed ID: 35187752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
    Liu Y; Wang W; Li Y; Huang Y
    Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
    Li C; Xin H; Shi Y; Mu J
    Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway.
    Zhang H; Zhong L; Wang M; Wan P; Chu X; Chen S; Zhou Z; Shao X; Liu B
    Mol Carcinog; 2024 Nov; 63(11):2063-2077. PubMed ID: 38994801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
    Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
    Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
    [No Abstract]   [Full Text] [Related]  

  • 19. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
    Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
    Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.